Innoviva (INVA) EBIT (QoQ) (2010 - 2026)
Innoviva (INVA) EBIT (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 376.02% |
| Dec 31, 2025 | -111.08% |
| Sep 30, 2025 | 155.91% |
| Jun 30, 2025 | 17.68% |
| Mar 31, 2025 | 493.09% |
| Dec 31, 2024 | -108.52% |
| Sep 30, 2024 | 126.25% |
| Jun 30, 2024 | 425.40% |
| Mar 31, 2024 | -155.49% |
| Dec 31, 2023 | -105.01% |
| Sep 30, 2023 | 519.44% |
| Jun 30, 2023 | -44.43% |
| Mar 31, 2023 | -109.86% |
| Dec 31, 2022 | -114.41% |
| Sep 30, 2022 | 398.20% |
| Jun 30, 2022 | -62.20% |
| Mar 31, 2022 | -145.09% |
| Dec 31, 2021 | -102.24% |
| Sep 30, 2021 | 180.27% |
| Jun 30, 2021 | 912.08% |